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Abbreviations
mg/gC Microgram per gram of creatinine
mg/m3 Microgram per cubic meter
mg/L Microgram per liter
95% CI 95% conﬁdence interval
g-GT Gamma glutamyltranspeptidase
CFS Chronic fatigue syndrome
ICD-9 International Classiﬁcation of Disease, Version 9
IgE Immunoglobulin type E
LBW Low birth weight
MS Multiple sclerosis
NAG N-acetyl-b-glucosaminidase
NECAT New England Children’s Amalgam Trial
OR Odds ratio
Introduction
It has been known since ancient times that mercury metal combines with other metals to form solid amalgams. The Chinese, during
the Tang Dynasty in the 7th century AD, may have been the ﬁrst to employ amalgam compositions for restoration of decayed tooth
structure and function. Modern use of amalgam restorations in dentistry dates to about 1818 when they were reinvented by Louis
Regnart, a Paris physician. Before amalgams, tooth ﬁllings were made from various materials, including gold foil and molten metal
mixtures. The former was expensive and the latter painful. Amalgam use in dentistry has been controversial since around the 1830s,
in part because it threatened the proﬁtable use of gold as a ﬁlling material, but also because of health concerns about mercury.
Dental amalgamwas introduced to the United States in 1833 by the Crawcour Brothers, who called it “Royal Mineral Succedaneum”
(meaning “gold substitute”). The brothers made a lot of money in a short time by appealing to wealthier patients, but their dubious
methods led to an increase in the level of opposition to amalgam.
The controversy has revived over the last 40 years or so, since analytical chemistry techniques became sensitive enough to show
continuous release of mercury from dental amalgams. Some of this mercury is absorbed into the body and studies have repeatedly
conﬁrmed that amalgams constitute the main source of inorganic mercury exposure in nonoccupationally exposed populations.
Experts groups established by various international and regulatory agencies have considered the evidence for whether amalgam
restorations may cause health damage. These groups have usually concluded that there was no evidence of harmful effects and,
therefore, no basis for recommending against the continuing use of amalgams. However, in 2006, the Dental Products Panel, an
advisory committee of the FDA, concluded that the available evidence on dental amalgams “neither supports nor refutes adverse
health effects.” In response, in July 2009, the FDA classiﬁed dental amalgam as a Class II (moderate risk) medical device and
imposed several labeling requirements for amalgam products. At the same time, the agency concluded that “exposures to mercury
vapor from dental amalgam do not put individuals age six and older at risk for mercury-associated adverse health effects.” This
remains the agency’s position.
Amalgams ﬁllings presently contain about 50%mercury, with the remainder mainly silver, with small amounts of copper, tin, or
zinc. Although alternative ﬁlling materials are increasingly available, amalgam remains popular because of its comparative cheap-
ness, durability, ease of use, and because it is less affected by moisture than other materials.
In 2013, the Minamata Convention on Mercury, intended to reduce exposures to and emissions of mercury and its compounds,
was signed by representatives of the majority of countries in the world. It contains special provisions for dental amalgams,
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consisting of nine measures that countries make take, depending on their circumstances. These include national objectives for
dental caries prevention and promoting the use of cost-effective and clinically effective alternatives for tooth restoration. Each rati-
ﬁer of the convention is required to implement at least two of the measures.
Although there is general consensus that the use of dental amalgams is decreasing across the world, they remain the most
frequently used ﬁlling material in posterior teeth, particularly in low and middle income countries. Before the advent of the Min-
amata Convention, a few, mainly Scandinavian, countries banned the use of amalgam ﬁllings, particularly because of concerns
about the potential for environmental mercury pollution. It has been estimated that, annually, about 7000 kg of amalgam-
related mercury were released from crematoria worldwide, constituting about 0.8% of anthropogenic mercury emissions to the
environment.
Apart from health concerns associated with release of mercury from amalgams, other disadvantages are esthetic, because of the
color of the ﬁllings, and, because has amalgam has no natural adherence to teeth, more healthy tooth must be removed to provide
a mechanical foothold for the amalgam ﬁlling. Restorations made of composite resin and ionomer cement materials are much
closer to tooth coloring and bond adhesively to healthy dentin. However, these alternatives are generally not as robust as amalgam
ﬁllings and require more frequent replacement, although materials are continually improving. The alternative materials are also
usually considerably more expensive than amalgam restorations. Table 1 provides a comparison of key characteristics for amalgam
ﬁllings and their main alternative–composite resin ﬁllings.
That there is mercury exposure from amalgam ﬁllings is no longer at issue. The question is whether this exposure causes harm to
health. A scientiﬁcally-based answer to this question is important. If health effects do occur, then many hundreds of millions of
people may be affected. Without overdoing the analogy, the experience with adding lead to gasoline, long thought to be of no toxi-
cological consequence, teaches us the importance of carefully examining low-level population exposures to toxic metals. On the
other hand, if amalgam ﬁllings are safe, then unnecessary restrictions on their use could have major economic and public health
consequences. If amalgam restorations were banned, then dental treatment would likely become prohibitively expensive for
some or many people.
Effects of inorganic mercury on the nervous and renal systems are long established. However, mercury may also affect the
immune, cardiovascular, respiratory, hematologic, gastrointestinal, and reproductive systems. Binding of mercury to the sulfhydryl
groups of enzymes may be the mediator of many of these effects. Most information about the health effects of inorganic mercury
exposure has come from studies of occupationally exposed populations. This information is relevant to assessment of the potential
for amalgam ﬁllings to cause health damage, but because the population of people with amalgam restorations contains younger,
older, and possibly more susceptible people than occupationally exposed populations, and because exposure to amalgam restora-
tions can be over a much longer time period, it is important that the safety of amalgams be conﬁrmed with population-based epide-
miologic studies.
This article considers the evidence for the safety of dental amalgam ﬁllings and draws on studies of other inorganic mercury-
exposed groups insofar as they may contribute usefully to the discussion. Exposures to organic mercury compounds (e.g., from
ﬁsh or vaccine preservatives) are not considered, as the nature of their toxicity is quite different from that of inorganic mercury.
The signs and symptoms of inorganic mercury toxicity, sometimes referred to as “mercurialism,” are well-established. Depending
on the exposure, these include erethism (psychotic symptoms, including excessive timidity, anxiety, a desire to remain unobserved
and unobtrusive, a pathological fear of ridicule with an explosive loss of temper when criticized), intention tremor, stomatitis, gingi-
vitis, and excessive salivation. These manifestations of mercury toxicity are not discussed in this article, as the levels of mercury expo-
sure from amalgam restorations are generally considered insufﬁcient to cause them. The emphasis here is on (i) possible effects of
mercury for which there has been more uncertainty, such as cardiovascular disease, neurodegenerative diseases, reproductive effects
and effects in children; and (ii) toxic effects of mercury known to occur, but for which there is debate about whether they are caused
by the levels of mercury exposure to which amalgam restorations may give rise (e.g., kidney effects).
Table 1 Comparison of Amalgam ﬁllings and composite ﬁllings
Amalgam Composites
Easy to use (by dentists) Requires higher skill level
Some bacteriostatic properties Not bacteriostatic
Durable Generally less durable, although improving
Highly resistant to wear Less resistant to wear
Tolerant to moisture Not moisture tolerant
Relatively inexpensive Appreciably more expensive
Not esthetic in appearance Esthetic appearance
Requires more removal of healthy tooth tissue to provide
mechanical grip
Only removal of decayed tissue
Incomplete data on toxic hazards Incomplete data on toxic hazards
Environmental mercury pollution (waste amalgam and
cremation) a concern
Pollution not of concern
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Mercury Uptake From Dental Amalgam
Amalgam ﬁllings continuously release low levels of mercury vapor. Most is as Hg0, which may be inhaled. Some mercury will be
oxidized to Hg2þ in the saliva and may be swallowed with small mercury particles from tooth abrasion caused by chewing and
bruxism. There is some evidence that some of the released mercury may be transformed to methylmercury by bacteria in the
oral cavity. The release rate of inorganic mercury will be determined by factors such as restoration size, the tooth and tooth surface
on which it is placed, chewing habits, food type and texture, tooth grinding and brushing, and the surface area, chemical compo-
sition, and time since placement of the restoration. Inorganic mercury is absorbed from the gastrointestinal tract at a rate of no
>10%. About 80% of mercury vapor reaching the lungs is absorbed. Any methylmercury generated by oral bacteria would be
>95% absorbed.
Correlations have been demonstrated between the number of amalgams and expired breath and urinary mercury concentrations.
In a population-based sample of 1626 U.S. women, aged 16–49, recruited by the 1999–2000 National Health and Nutrition Exam-
ination Survey, it was estimated that for every 10 dental amalgam-ﬁlled tooth surfaces an increase in urinary mercury of about 1.8 mg
per gram of creatinine (mg/gC) would occur (Dye et al., 2005). From a study of 550 nonoccupationally exposed adults, Fig. 1 shows
a monotonic increase in urinary mercury levels in relation to number of amalgam ﬁllings. It also shows that there is a strong rela-
tionship with the number of occlusal (top surface) amalgam ﬁllings (Factor-Litvak et al., 2003).
People with amalgam ﬁllings who chew gum regularly, particularly those who use nicotine-containing gum as a smoking
cessation aid, may be the most highly exposed. Urinary mercury levels in nicotine gum users have been shown to be in the range
2.8–14 nmol/nmol creatinine, which approaches the biological exposure index for mercury in urine of 20 nmol/nmol creatinine
(35 mg/gC) set by the American Conference of Governmental Industrial Hygienists as an acceptable limit for occupational
exposures.
Subjects with amalgam ﬁllings tend to have higher concentrations of mercury in saliva and feces and the number of amalgam
surfaces has been shown to be correlated with the mercury content of several tissues, including the kidney and brain at autopsy.
Signs and symptoms of mercury toxicity in occupational studies have usually occurred in association with mercury concentra-
tions in air of >50 mg/m3. These correspond to urinary mercury concentrations of >100 mg/L. Urinary mercury concentrations in
people who have had no occupational mercury exposure may be as high as 20 mg/L.
For people without occupational exposure to mercury, daily absorption of mercury from ambient air is around 0.24 mg,
compared to 3–17 mg from amalgam restorations. It has been estimated that in the Australian context, mercury derived from dental
amalgams constitutes about 25%–50% of total body burden of mercury.
The change in mercury content of body ﬂuids (blood, serum and urine) after removal of amalgam ﬁllings has been investigated.
In one study, 12 subjects were followed for up to 3 years after their amalgam ﬁllings were removed using high-speed water-spray
cutting and a vacuum extractor, but no rubber dam. After a transient initial increase in mercury content of blood and plasma, the
serummercury concentrations in these ﬂuids and urine continued to decrease, according to a bi-exponential model, for the remain-
ing period of follow-up, approaching concentrations found in people who had had no amalgam ﬁllings placed.
Other studies have found an initial transient increase in urinary excretion of mercury after amalgam removal. This has been fol-
lowed to a decline in urinary mercury levels to around 25% of their preremoval levels, after 1 year.
Chronic Disease Incidence and Mortality
During 1968–69, 1462 Swedish women, aged 38–60, received medical and dental examinations at recruitment into a prospective
cohort study. In the data analysis, the number of amalgam ﬁllings at recruitment was investigated in relationship to episodes of
myocardial infarction, stroke, diabetes, or cancer, and to overall mortality occurring over a 20-year follow-up period. Women
Fig. 1 Relationships between UHg (mg/g creatinine) and (A) the number of total mercury-containing amalgam surfaces, and (B) the number of
occlusal mercury-containing amalgam surfaces. Error bars represent 1 SD above the mean. Source: Factor-Litvak, P., Hasselgren, G., Jacobs, D.,
et al. (2003). Mercury derived from dental amalgams and neuropsychologic function. Environmental Health Perspectives 111, 719–723.
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with 20 or more amalgam-ﬁlled surfaces (n ¼ 632) were compared with dentate women having 0–4 amalgam ﬁllings (n ¼ 180).
Having a larger number of amalgam-ﬁlled surfaces was associated with lower risks for myocardial infarction, stroke, diabetes, and
overall mortality (Ahlqwist et al., 1993).
Blood samples were collected at recruitment and analyzed for mercury content. The serum mercury concentrations were corre-
lated with the number of amalgam restorations then present (r ¼ 0.84, P < 0.0001). General mortality, myocardial infarction,
stroke, diabetes, and cancer were assessed after 24 years of follow-up (Ahlqwist et al., 1999). No health outcome was associated
with serum mercury concentration, but, after adjusting for age and education, there was a negative correlation with mortality
rate (P ¼ 0.05).
Since it is not likely that amalgams have a directly protective effect, this result is probably a result of confounding by access to
dental treatment. In other words, healthier people may have better dental treatment access and receive more amalgam restorations.
The one other epidemiologic study with a large number of subjects that examined a broad range of health outcomes in relation
to dental amalgam exposure is a retrospective cohort study of New Zealand military personnel (Bates et al., 2004). Within the New
Zealand Defense Force dental treatment has been compulsory, regular, and without regard to rank. Longitudinal, tooth surface-
speciﬁc dental treatment records for the study’s 20-year follow-up period were available. These permitted construction of a time-
varying exposure index expressed as amalgam surface-years. The cohort of 20,000 people was linked with national mortality,
hospital discharge and cancer incidence records for the period 1977–1997. There were no associations between the amalgam expo-
sure index and broad disease outcome categories. Nor were any associations identiﬁed between the exposure index and any speciﬁc
causes of death or cancers. However, at the end of follow-up the cohort was still quite young and there had been few deaths
(n ¼ 189) or cancers (n ¼ 264). Results for some of the more speciﬁc outcomes are summarized separately below.
Neurologic Disease
Given that inorganic mercury is well-established as affecting the nervous system, it is perhaps not surprising that much concern has
focused on possible associations between dental amalgam restorations and nervous system diseases, particularly diseases for which
the etiology is still largely unclear–multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. There have also been concerns
about possible neuropsychological and neurophysiological effects of mercury release from dental amalgam ﬁllings.
Multiple Sclerosis
The fact that both multiple sclerosis (MS) and dental caries prevalences tend to increase with increasing distance from the equator
prompted suggestions of a common etiology. Later, it was hypothesized that this association may really be an association of MS
with dental amalgam restorations, more prevalent in high caries areas. Since then there have been several studies investigating
this possibility.
In one study a symptom questionnaire was administered to 42 MS patients whose amalgam restorations had been removed and
44 MS patients who retained their restorations (Siblerud and Kienholz, 1994). The group that still had their amalgams reported an
average of 34%more MS-related symptoms within the last year than the amalgam removal group. The ﬁndings are difﬁcult to inter-
pret because of a difference in the method by which the two participant groups were recruited. Subjects retaining their amalgams
were recruited in part through advertisements. This approach may have tended to attract people with more severe MS symptoms.
Also, MS diagnoses were apparently not veriﬁed and there could have been a placebo effect from the amalgam removal.
Three epidemiologic case-control studies have investigated whether there is an association between MS and dental amalgams. A
study in Canada recruited 143 incident MS cases and 128 age- and sex-matched controls (Bangsi et al., 1998). Dental histories were
obtained from personal dentists. In the cases and controls, average numbers of amalgam ﬁllings were 9.4 and 8.8, respectively
(P > 0.05). Exposure-response relationships, based on a count of amalgam restorations and, separately, on time since placement
of the ﬁrst amalgam ﬁlling, provided weak evidence of increasing risk.
The second case-control study involved 39 English female MS cases, aged 25–65 at diagnosis (McGrother et al., 1999). Cases
were diagnosed during 1977–85, but the study was conducted in 1989–90. Sixty-two age-matched controls were obtained from the
same physician patient lists as the cases. During the study, all subjects received a full dental examination. Cases and controls had
average numbers of 8.9 and 9.7, amalgam-ﬁlled teeth (P ¼ 0.40). Prevalent cases of MS, some of whom had all their amalgam ﬁll-
ings removed after diagnosis, were used in this study. Also, compared to the controls, cases had often neglected their dental treat-
ment. These features, consequential on using prevalent rather than incident cases, would probably have obscured any actual
relationship between MS and amalgam restorations.
The third case-control study, from Italy, used 132 MS cases diagnosed in the last 16 years and 423 controls matched on sex, age,
and residential area (Casetta et al., 2001). Information on amalgam restorations was obtained by questionnaire, from the study
subjects themselves. Cases reported larger numbers of dental ﬁllings than controls (P < 0.05). In those study subjects for whom
the duration since ﬁrst amalgam placement was >5 years, there was a weakly increasing trend in the odds ratios associated with
the number of amalgam ﬁllings. Limitations of this study included use of prevalent cases and the method of obtaining amalgam
restoration data. Individuals are unlikely to accurately recall when and howmany amalgam restorations they have had. Such recall is
very likely to be subject to bias, particularly if some MS patients believed their condition was caused by their amalgams.
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Finally, the previously mentioned cohort study of New Zealand military personnel obtained a relative risk estimate of 1.24 (95%
CI: 0.99–1.53, P ¼ 0.06) for a cumulative exposure unit of 100 amalgam-ﬁlled surface-years. For a person with the average cumu-
lative exposure in the cohort of 628 amalgam-ﬁlled surface-years, this equates to a relative risk estimate of 3.9, compared to
someone who has had no amalgam ﬁllings.
Overall, the available studies are few, none are recent, and together they are inconclusive. Study limitations include small
numbers of study subjects or MS cases, use of prevalent cases lack of conﬁrmation of case diagnoses, and inadequate amalgam expo-
sure data.
Parkinson’s Disease
A classic symptom of mercury poisoning, as it is for Parkinson’s disease, is ﬁne tremor of the hands. This is, at least in part, one
reason why mercury has been suspect in Parkinson’s etiology. However, the tremor frequency associated with mercury exposure
is higher than found with Parkinson’s disease. Nonetheless, it has long been suggested that dental amalgams might be a cause
of Parkinson’s disease, for which there are no conﬁrmed environmental causes, although some pesticides are suspected.
Two epidemiology study have investigated whether dental amalgams are associated with Parkinson’s disease. The ﬁrst, a German
case-control study compared 380 prevalent Parkinson’s disease patients with 379 neighborhood controls and 376 regional controls
(Seidler et al., 1996). At the interview, cases were asked how many amalgam ﬁllings they had before Parkinson’s disease onset;
controls were asked how many amalgam ﬁllings they had 1 year before interview. On average, study cases reported more amalgam
ﬁllings (n ¼ 7.8) than either neighborhood controls (n ¼ 6.5, P ¼ 0.0008) or regional controls (n ¼ 6.1, P < 0.00005). Using the
regional controls and after adjustment for the number of remaining teeth, odds ratios for increasing exposure in quartiles of
amalgam ﬁllings per remaining number of teeth, relative to the low exposure quartile, were 1.7 (95% CI: 1.0–2.7), 2.5 (1.4–
2.5), and 1.9 (1.1–3.3) (P for trend ¼ 0.003). The use of prevalent Parkinson’s cases and amalgam exposures based on self-
report at interview were major limitations of this study. Dental records or dental examinations were not used.
Most recently, a retrospective cohort study of the association between Parkinson’s disease and dental amalgams was carried out
using the Taiwanese National Health Insurance Research database, which contains dental amalgam placement data since 2000 (Hsu
et al., 2016). 10,236 persons with amalgam ﬁllings during the period of follow-up (2002–08) were individually age- and sex-
matched with 10,236 persons who did not receive such ﬁllings. Incidence rates of Parkinson’s disease diagnosis across the
follow-up period were compared between the two groups. Incidence rates in the two groups were 2.35 and 1.04 cases per 1000
person-years of follow-up for the amalgam and non-amalgam groups, respectively. The adjusted hazard ratio (HR) was 1.58
(95% CI: 1.12, 2.23). Co-variate adjustment was carried out only for co-morbidities, particularly diabetes, hypertension, hyperlip-
idemia and cardiovascular disease. Notable about this study was the high rate of all these co-morbidities in the amalgam group
compared to the non-amalgam group. There are at least two conceivable explanations for this: either amalgam ﬁllings are a cause
of the differences in co-morbidities between the two groups or people receiving amalgam ﬁllings are substantially different in terms
of their health or socio-economic statuses from people not receiving amalgam ﬁllings. Based on present knowledge, the latter expla-
nation seems more likely. The other consideration is that the study was unable to take into account amalgam ﬁllings before about
2000, although the overall impact of such exposure misclassiﬁcation is likely to have been nondifferential and attenuated the
hazard ratios. So that in itself would be unlikely to explain the elevated HR obtained.
In conclusion, the evidence for an association of dental amalgam ﬁllings and Parkinson’s disease is very limited, although data-
bases such as the one used in Taiwan offer a potentially valuable and cost-effective means of investigating this association.
Alzheimer’s Disease
Although there have long been claims that dental amalgam ﬁllings may be a cause of Alzheimer’s disease there has been little effort
to investigate this hypothesis. An Alzheimer’s disease case-control study investigated whether there was an association with dental
amalgam exposure (Saxe et al., 1999). The study included 68 Alzheimer’s cases at autopsy and 33 controls obtained from a volun-
teer brain donation program. Dental histories were available from dental records and X-rays for both cases and controls. Mercury
analyses were carried out for samples from the brain cerebral cortexes. Three amalgam exposure indexes, based on “event”
(amalgam placement, repair or removal) and location and after placement, were used. No associations were found between any
of the exposure indices and either Alzheimer’s disease or mercury concentrations in the brain. Although this study had high quality
dental history data, the number of subjects was small.
An ecological study of people in ﬁve Canadian regions obtained a correlation between prevalences of Alzheimer’s disease and
edentulism (Lund et al., 2003). This was interpreted by the authors as arguing against any association between amalgam restora-
tions (in people with teeth) and Alzheimer’s disease. However, it could be argued that the reverse is the casedsince prevalence of
edentulism is an indicator of higher caries rates, the edentulous group might have had a higher past exposure to amalgams.
In an Australian study that examined occupational risk factors for Alzheimer’s disease, a panel of occupational hygienists eval-
uated job details for 170 Alzheimer’s disease cases and 170 age- and sex-matched controls (Gun et al., 1997). An odds ratio of 1.78
(95% CI 0.44–2.85) was obtained for occupational exposure to mercury. However, only 4.1% of the cases and 2.4% of the controls
had had mercury exposure.
Most recently a study took advantage of the Taiwanese Longitudinal Health Insurance Database, which contains health data,
including recording of dental amalgam ﬁllings placed since 2001 (Sun et al., 2015). The study included a total of 207,657
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beneﬁciaries aged 65-years and older in 2010. For placement of any amalgam ﬁllings in the period 2001–10, the ORs for association
with Alzheimer’s disease were 1.07 (95% CI: 0.96–1.20) for men and 1.13 (1.02–1.25) for women. Although suggestive of an asso-
ciation, co-variate adjustment was carried out only for age, income, and Region of Taiwan. Small measures of effect, such as those
obtained in this study, could easily be inﬂuenced by unmeasured confounding factors or other bias. Nonetheless, databases such as
was used in this study offer excellent opportunities for exploring such associations, particularly if a wider range of covariates is
available.
Overall, the available studies provide only limited evidence for a role of dental amalgams or mercury in Alzheimer’s disease
etiology.
Neuropsychological and Neurophysiological Function
There have been a number of studies that investigated whether amalgams were associated with neuropsychological or neurophys-
iological functioning. A study of 129 nuns, aged 75–102, living in a retirement home used an intraoral camera to assess coexisting
amalgam placements (Saxe et al., 1995). Results of eight cognitive function tests completed by the nuns provided no evidence of
deterioration of performance that was correlated with amalgam restorations. Although this study had good data on existing
amalgam restorations, it lacked information on duration of placements.
A study using 587 participants drawn from the Swedish Twin Registry, obtained self-rated health assessments and the results of
tests of personality and memory function (Bjorkman et al., 1996). Dental status was obtained by oral examination. Suggestions
that a higher number of amalgam surfaces was associated with better health mostly disappeared after adjusting for age, sex, educa-
tion, number of teeth, and smoking behavior. The lack of information on duration of amalgam ﬁlling placement would have weak-
ened any true causal associations that were present.
A well-conducted study of 550 residents of New York, aged 30–49 years, obtained a correlation between urinary mercury excre-
tion and both the total number of amalgam-ﬁlled surfaces and the number of amalgam-ﬁlled occlusal surfaces (Factor-Litvak et al.,
2003). No associations were found between scores on neuropsychological tests and either urinary mercury concentrations or
numbers of amalgam restorations. This study also did not have information on duration since placement of ﬁllings.
There have been few studies of whether amalgam restorations are associated with reductions in peripheral nerve function.
However, neurologic examinations (not including nerve conduction testing) and quantitative sensory testing were carried out
on 2038 U.S. military personnel (Kingman et al., 2005). Amalgam exposure (total number of ﬁlled surfaces) was assessed by
oral examination. No associations were found between amalgam exposure and either clinical neuropathy signs or sensory thresh-
olds. Again, a study limitation (acknowledged by the authors) was the unavailability of longitudinal amalgam placement and
removal data.
Two clinical trials, described in more detail below, in both of which children were randomly allocated to one of two treatment
groups, receiving either amalgam or resin composite ﬁllings, found no evidence for deleterious effects on neuropsychological devel-
opment associated with amalgams. One of these studies, the New England Children’s Amalgam Trial (NECAT), followed 534 chil-
dren for 5 years, beginning at ages 6–10 (Bellinger et al., 2006). The Casa Pia study followed 507 children aged 8–10 in Lisbon,
Portugal, for 7 years (DeRouen et al., 2006). The latter study also carried out nerve conduction tests and found no difference
between the two groups.
In summary, the studies provide no support for an effect of amalgam restorations on neurologic function.
Auditory System Effects
A British study, prompted by knowledge of mercury ototoxicity, investigated whether dental amalgam ﬁllings were associated with
hearing loss (Rothwell and Boyd, 2008). It recruited 39 non-smoking women, aged 40–45, with no history of hearing or ear prob-
lems. Their ﬁllings were counted by a dentist and their hearing thresholds were measured using pure-tone air-conduction audiom-
etry. Increasing numbers of amalgams were associated with poorer hearing thresholds, measured in decibels (dB), between
frequencies of 8 and 16 kHz, and possibly as low as 4 kHz. The strongest association, at 14 kHz, shows a clear trend of increasing
hearing threshold (i.e., poorer hearing) with number of amalgam ﬁllings at time of examination (R2 ¼ 0.35, P < 0.001). This was
equivalent to a worsening of hearing threshold for each amalgam by 2.4 dB (95% conﬁdence interval: 1.3, 3.5 dB). No other pub-
lished study has attempted to conﬁrm these results.
Effects on Immunologic Function
Animal experiment have generated autoimmune responses to low inorganic mercury doses, particularly an increase in immuno-
globulin type E (IgE).
A Swedish study found a statistically signiﬁcant correlation between immunoglobulin type A (IgA) and plasma mercury
concentration, but no correlation of plasma mercury with IgE in 15-year olds (Herrstrom and Hogstedt, 1994). A follow-up study
in 19-year old students (n ¼ 77), half with allergic diseases (asthma, allergic rhinitis, eczema), provided no conﬁrmation of the
correlation between IgA and plasma mercury concentration (Herrstrom et al., 1997). There was also no association of plasma
mercury concentration with IgE or with allergic disease, but a correlation with IgG2 was found (r ¼ 0.33, P ¼ 0.003).
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No associations were found with numbers of amalgam restorations, when 33 children with Henloch-Schönlein purpura and
another 31 with acute glomerulonephritis, both autoimmune diseases, when these children were compared with a matched control
group (Herrstrom et al., 1996).
So far, the only detrimental health effect unequivocally associated with dental amalgams is allergic reactions in the mouth. These
are very rare and usually improve after removal of the amalgam restorations.
Effects on Kidney Function
It is well established that the kidney is one of the primary target organs of inorganic mercury exposure, particularly at higher doses.
Most known examples involve occupational exposures or ingestion of mercury in traditional medicines or teething powders. Mani-
festations can range from increased urinary excretion of certain proteins, such as N-acetyl-b-glucosaminidase (NAG), transferrin or
b2-microglobulin, the nephrotic syndrome (edema and albuminuria) and acute renal failure.
Concerns about possible renal effects of dental amalgam mercury release were prompted by a study showing reduced inulin
clearance by the kidneys and changes in urinary electrolyte patterns in six sheep, each given 12 occlusal ﬁllings (Boyd et al.,
1991), although this study has been criticized as involving an unrealistic exposure scenario.
That people with amalgam restorations have higher kidney mercury concentrations than people without amalgams has been
conﬁrmed in several studies (Nylander et al., 1987, Barregard et al., 1999). Other studies have investigated renal function in rela-
tion to amalgam loading. A study of 48 healthy male students, aged 17–22 years, found no association between urinary proteins
indicative of kidney damage and either number of dental amalgam restorations or urinary mercury levels (Herrstrom et al., 1995).
Another study involving 100 healthy adults, 18–44 years, detected a small increase in urinary NAG levels in people with
amalgam ﬁllings, but the authors considered it to have probably no clinical signiﬁcance (Eti et al., 1995).
Renal function changes after removal of an average of 18 amalgam ﬁllings from 10 healthy volunteers were investigated
(Sandborgh-Englund et al., 1996). Signiﬁcantly lower mercury levels were present in urine 60 days after the amalgam removal,
but there was no change in renal function indicators.
A retrospective cohort study of 20,000 New Zealand military personnel found no associations between an index of longitudinal
dental amalgam exposure and any of a number of kidney diseases found in hospital discharge data (Bates et al., 2004).
Finally, two randomized trials in children, described in more detail below, measured kidney function in a group with
amalgam ﬁlling placements with a group that received composite resin ﬁllings. Measures of glomerular and tubular kidney func-
tion measured in the NECAT were urinary albumin, alpha-1-microglobulin, g-glutamyl transpeptidase (g-GT) and NAG (Barre-
gard et al., 2008). The only difference in the markers between the two groups was that, relative to children in the composite
group, children in the amalgam group had an elevated prevalence of microalbuminuria (deﬁned as urinary albumin >30 mg/
g creatinine) in years 3 and 5 of the 5 years of follow-up (adjusted OR ¼ 1.8, 95% CI: 1.1–2.9). However, there was no signiﬁcant
increase in the microalbuminuria associated with either the number of amalgam ﬁllings (P ¼ 0.30) or urinary mercury excretion
levels (P ¼ 0.71).
Also of note in the NECAT study was the absence of any association of amalgam treatment with NAG. A study of children living
around nonferrous metal smelters in several European countries found increased levels of NAG associated with urinary mercury
levels lower than those found in the NECAT children (de Burbure et al., 2006). However, it is possible that the results of the Euro-
pean study reﬂect uncontrolled confounding or interactions with other exposures, particularly metals.
The other randomized trial, the Portugal-based Casa Pia study, measured urinary albumin and g-GT in the children in the study
(Woods et al., 2008). This study found no differences between the treatment groups over the course of the 7-year follow-up,
including no difference in the prevalence of microalbuminuria.
The difference between the two randomized children’s trials in results for microalbuminuria is not readily explained by differ-
ences in exposure, as children in the amalgam treatment group in NECAT had lower mean numbers of tooth surfaces restored with
amalgam and surface-years of amalgam exposure (11.5 and 31.7, respectively) than the amalgam-treated children in the Casa Pia
study (16.1 and 50.1, respectively). The authors of the NECAT study suggested that their albuminuria result might be attributable to
chance (Barregard et al., 2008).
In summary, although studies are few, there is only very limited evidence that dental amalgam restorations may affect kidney
function and the preponderance of evidence suggests that they probably do not.
Studies of Self-Reported Symptoms
Various studies have investigated the relationship between dental amalgam restorations and self-reported symptoms. Broadly, these
studies fall under two general study designs:
1. Investigations of symptoms before and after amalgam ﬁlling have been removed. These are often case-series, sometimes large, in
which people have reported symptom relief after removal of their amalgam ﬁllings, or studies in which symptom changes are
compared in a group with and a group without amalgam removal. As well as symptom relief, diseases for which recovery has
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been reported after amalgam removal include Parkinson’s disease, Crohn’s disease, MS, epilepsy, asthma, scleroderma, paranoia,
and blindness.
2. Investigations of associations between symptom prevalence and measures of amalgam exposure, as estimated from dental
histories or dental examinations at the time of the study. These studies may involve a comparison between a group of people
who believe themselves harmed by their amalgam ﬁllings and a group of people without such belief.
Of these two study designs, results of the ﬁrst are very likely to be inﬂuenced by an uncontrolled placebo effect. Therefore, they
contribute little to the debate and are not considered further here. Results of the second study design are less likely to be inﬂuenced
by the placebo effect, although they still may be affected by other types of bias. Studies of this type are brieﬂy reviewed here.
Self-perceived health was compared in 50 college students who had an average of 10 amalgam ﬁllings with 51 students with
no amalgam ﬁllings (Siblerud, 1989). Subjects with amalgams reported being less happy, as well as more frequent suicidal
tendencies. The amalgam group reported 61% more symptoms overall. This group also reported heavier consumption of sweets,
alcohol, cigarettes and coffee than the nonamalgam group. Interpretation is difﬁcult because results are potentially confounded
by these differences. The amalgam subjects had a signiﬁcantly higher average blood pressure than the non-amalgam group, as
well as reporting a signiﬁcantly greater frequency of heart or chest pains and tachycardia, and were more likely to suffer from
tiredness, chronic fatigue, and anemia (Siblerud, 1990). In the data analysis there was no adjustment for the lifestyle factors.
Other studies have generally reported no associations between amalgam restorations and symptom prevalence. A study in Swe-
den of 1024 dentate women, aged 38–72, found no positive correlations between symptoms and the number of amalgam ﬁllings,
but a few symptoms were inversely correlated with amalgam numbers (Ahlqwist et al., 1988).
A Norwegian study compared 99 patients who self-referred with multiple symptoms, that they personally considered were
caused by their amalgam ﬁllings, to 272 other patients (Malt et al., 1997). No correlation was found between symptom prevalence
and number of ﬁllings. In another study, 50 Swedish patients who self-referred because of symptoms that they considered were
caused by their dental amalgams were compared to a matched comparison group of 50 patients (Bratel et al., 1997a,b). Average
numbers of amalgam surfaces in the two groups were much the same (28.2 and 29.0, respectively).
In a large German study that examined prevalence of 48 different symptoms in 4787 patients, aged 21–60, a greater number of
amalgam-ﬁlled surfaces was associated with a lower prevalence of symptoms (Melchart et al., 1998). A similar result was found in
a study of 587 individuals, aged 46–89 (mean: 66), drawn from the Swedish Twin Registry (Bjorkman et al., 1996).
Similar results were found in two other studies, each with about 40 patients who considered themselves harmed by amalgams
and 40 referent subjects (Bailer et al., 2001,Ganss et al., 2000). Both studies found no differences between the compared groups in
terms of numbers of amalgam ﬁllings or blood or urinary mercury levels.
Chronic fatigue syndrome (CFS) (ICD-9 code 780) is a condition, involving symptoms, but usually no objective signs. There has
been a widespread popular belief that CFS is associated with dental amalgams, but little epidemiological study of this hypothesis. A
retrospective cohort study of New Zealand military personnel found no association between cumulative dental amalgam exposure
and CFS (Bates et al., 2004). The relative risk estimate for CFS in relation to an exposure unit of 100 amalgam-ﬁlled surface-years
was 0.98 (95% CI: 0.94–1.03).
In summary, the preponderance of evidence, particularly from larger studies, suggests amalgam restorations are not associated
with subjective symptoms or chronic fatigue syndrome.
Reproductive Effects
Generally, epidemiological studies have shown little or no effect of inorganic mercury on reproductive parameters, including
fertility. In the cohort study of New Zealand military personnel described above there were 1062 births categorized as “complica-
tions of pregnancy and childbirth” (ICD-9 codes 630-677), but no association between these conditions and cumulative amalgam
exposure.
Studies have investigated whether mothers’ dental treatment during pregnancy affects the birth outcome. A case-control study in
Washington State of 1117 low birth weight (LBW) infants and 4468 controls found no association of LBWwith placement of dental
amalgam ﬁllings in the mothers during their pregnancies (Hujoel et al., 2005). Another study found no associations between place-
ment or removal of dental amalgams in mothers’mouths during pregnancy with gestational age, birthweight, or the child’s commu-
nicative ability at 15 months of age (Daniels et al., 2007). However, as acknowledged by the authors, collection of dental treatment
by mailed questionnaire at 33 months postpartum is likely to be associated with nondifferential recall error that would bias any true
associations towards the null.
Even though there is little evidence for reproductive effects induced by dental amalgams, there is evidence of in utero exposure:
hair levels of mercury in fetuses have been shown to be correlated with the number of amalgam ﬁllings that their mothers have.
Effects in Children
Until relatively recently there had been relatively few epidemiological studies of health effects of amalgam ﬁllings in children and no
health effects had been associated with either mothers’ amalgam ﬁllings (in utero or breast milk transfer) or amalgam ﬁllings in
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older children. The results of two randomized trials in children have been published. The ﬁrst of these, the New England Children’s
Amalgam Trial (NECAT), conducted between 1997 and 2005, involved 534 children who, at baseline, were aged 6–10 years, had no
previous amalgam ﬁllings, and had at least two posterior teeth with caries (Bellinger et al., 2006). These children were randomized
to two groupsddental amalgam or resin composite ﬁllings. The children were followed for 5 years, during which further ﬁllings
were placed while maintaining the treatment assignment. The study was sufﬁciently large to be able to detect a 3-point decline
in IQ in one group relative to the other group over the course of the follow-up. Study results showed no evidence of adverse effects
of amalgam in relation to IQ, neuropsychological function, psychiatric or behavioral symptoms, or kidney function (Bellinger
et al., 2006, 2007a,b, Barregard, 2008).
The other study, known as the Casa Pia study, involved randomizing 507 children, aged 8–10, in Lisbon Portugal to amalgam
and resin composite treatment groups. To be eligible for the study children needed to have at least one carious lesion on a perma-
nent tooth and have had no previous amalgam ﬁllings. Follow-up was for 7 years. No evidence of differences between the two
groups was found for measures of memory, attention, visuo-motor function, nerve conduction or kidney function (DeRouen
et al., 2006, Woods et al., 2008).
Overview and Conclusions
Probably billions of people throughout the world have mercury amalgam ﬁllings in their teeth. Although use of amalgam ﬁllings
has been decreasing, particularly in developed countries, it has been estimated that, between 1993 and 2008, about 900 million
dental amalgam ﬁllings were inserted in the United Statesdan average of 60 million per year.
Historically, people have been exposed to mercury from many sources, but there are now relatively few that are substantial.
Dental amalgam has been characterized as one of “the three modern faces of mercury” (Clarkson, 2002). The other two “modern
faces” are methyl mercury in ﬁsh and ethyl mercury (thimerosal), used as a preservative in vaccines. These three sources of exposure
share the characteristics of being very widespread, they are all associated with some beneﬁts, and for all of them there is some uncer-
tainty or controversy about possible health effects.
Exposures to mercury from dental amalgams are clearly below mercury exposures shown to cause health effects in studies of
people with occupational mercury exposure. However, studies of occupationally exposed populations commonly are affected by
selection bias, often termed the “healthy worker effect,” in which healthier people are selected into the workforce at the beginning
of employment and those who are more refractory to the effects of work exposures remain employed in the industry. Also, in epide-
miological studies of industrially exposed populations, durations of exposure and follow-up can be short, and occupational pop-
ulations may be too small to detect uncommon health effects. People with amalgam restorations constitute a broader population
spectrum and include more young, elderly and unwell people than are usually found in employed populations. Also, unless they
have a very long period of follow-up, occupational studies are less likely to detect risk increases in diseases that mainly occur in the
elderly (e.g., Alzheimer’s or Parkinson’s diseases) or nonmalignant diseases of low incidence (e.g., multiple sclerosis). Considering
the very large number of people with dental amalgam ﬁllings, even a quite small relative risk increase could have serious public
health implications. A rare effect caused by mercury (in teething powders) was acrodynia, also known as pink disease, which it
is estimated to have occurred in one exposed child in 500.
Despite 200 years of the modern period of use of dental amalgams and their ubiquitous prevalence, support for their continued
use has historically been based on absence of evidence of harm, rather than demonstrations of actual safety. Characteristic of ofﬁcial
statements is that by the US Food and Drug Administration, in 2002: “no valid scientiﬁc evidence has shown that amalgams cause
harm to patients with dental restorations, except in the rare case of allergy.” The American Dental Association has relied on such
assessments.
Accepting that it is difﬁcult to prove a negative, it is still appropriate to deﬁne types of harm that could potentially be caused by
amalgam ﬁllings and apply a systematic and critical evaluation method to available studies, particularly epidemiology studies, to
clearly deﬁne those areas of concern that have been adequately investigated and those which require further study. A different
approach to this evaluation, used by the FDA, is to rely on a comparison of estimated exposures to mercury from amalgam ﬁllings
against mercury exposure standards, as established by the US Environmental Protection Agency and the Agency for Toxic Substances
and Disease Registry (ATSDR). A disadvantage of this approach is that the reference standards are unavoidably based on limited data
and data obtained from small numbers of subjects. The subsequent numerical comparison of exposure versus standard does not
explicitly address these limitations and can give a misleading impression of certainty.
Considering the extremely widespread and long-standing nature of the exposure and that it is the main source of inorganic
mercury body burden in nonoccupationally exposed populations, there have been remarkably few analytic epidemiological inves-
tigations of possible health effects of dental amalgams. Studies that have been carried out have often had very small numbers of
participants or other methodological limitations that make interpretation difﬁcult or impossible. The chief limitation has been
amalgam exposure assessment, which has usually been based on the number of dental amalgam ﬁllings at time of the study
and has not taken into account how long the amalgams have been in place or other aspects of dental treatment history, such as
tooth loss. Most studies have involved some form of dental examination, but some studies have asked people to report their
own amalgam history, an approach likely to lead to a high degree of misclassiﬁcation, even of current amalgams.
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A difﬁculty in obtaining longitudinal amalgam exposure data is that people change dentists over the course of their lifetimes, but
their treatment records are often not transferred between dentists. Also, these records are not maintained by dentists in a consistent
way, making difﬁcult a comparison of amalgam placement histories across study participants. Another difﬁculty in study interpre-
tation is confounding by access to dental treatment. People in higher socio-economic groups usually have better access to dental
treatment. Because of this they may have more amalgam restorations. The same people are likely also to maintain better health.
It is likely that this accounts for associations between amalgam exposure and better health found in several population-based
studies. A cohort study of New Zealand military personnel went some way towards overcoming these limitations. These personnel
received regular and consistent dental treatment, regardless of rank, and comprehensive longitudinal treatment records were avail-
able for the period of military service.
Two randomized trials in children have provided important and much-needed reassurance about possible impacts of amalgam
placements in children. However, the cumulative exposure of the study participants was small in relation to lifetime exposure and
longer-term follow-up would be necessary to provide greater conﬁdence that there is not an eventual cumulative effect. Also, there
may be genetically susceptible sub-populations that have yet to be discovered.
In summary, despite the longstanding use of dental amalgam for tooth restoration, epidemiologic data to establish its safety are
less than ideal for such a widespread exposure. However, the data that are available are for the most part reassuring, particularly for
kidney diseases, effects on neuropsychological function, chronic fatigue syndrome, nonspeciﬁc symptom complexes, and effects in
children. A small study that appeared to show hearing loss associated with amalgam ﬁllings deserves to be followed up. Apart from
that, most in need of further study are neurodegenerative diseases, particularly MS, Parkinson’s disease, and Alzheimer’s disease, for
which the current evidence is limited and, to the extent that it exists, is equivocal. This is consistent with the views of the FDA. In
a statement accompanying the 2009 classiﬁcation of dental amalgam as a Class II medical device, the FDA stated that there is “a
paucity of studies” that evaluate a link between dental amalgam and neurological and neurodegenerative diseases, such as Parkin-
son’s disease, Alzheimer’s disease and MS. A 2015 review by an expert committee of the European Commission concluded that
“current evidence does not preclude the use of. amalgam. in dental restorative treatment.”However, it went on to say that “there
is a need for further research, particularly relating to evaluation of the potential neurotoxicity of mercury from dental amalgam and
the effect of genetic polymorphisms on mercury toxicity.”
Finally, the fact that this article has focused on mercury amalgam ﬁllings should not be taken to imply that the alternative ﬁlling
materials are safe. There are many such alternative materials now available. Although clinical use over the last 40 years or so has
revealed little in the way of harmful effects from these ﬁllings (other than allergies), they have not been comprehensively studied.
See also: Mercury Toxicity; Mercury in Air; Minamata Disease; Gold and Amalgams: Environmental Pollution and Health Effects.
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